This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Inactivated polio with DTP, DTP-HIB and DT

Authoring team

In the UK, the use or oral polio vaccine has been replaced by use of inactivated polio vaccine (1,2,3):

  • combined vaccine - diphtheria, tetanus, acelular pertussis, inactivated polio, haemophilus inflenzae type B and Hep B (DTaP/IPV/Hib/Hep B)
    • administered at two, three and four months old as part of the childhood immunisation schedule
  • combined vaccine - diphtheria, tetanus, acelular pertussis, inactivated polio vaccine (dTaP/IPV)
    • administered as part of the pre-school booster
  • diphtheria, tetanus and inactivated polio vaccine (Td/IPV)
    • recommended for boosting teenagers aged 13 to 18 years old
    • can also be used for primary immunisation in unvaccinated individuals aged 10 years and over
    • in consideration of travel vaccination - where tetanus, diphtheria or polio protection is required and the final dose of the relevant antigen was received more than ten years ago, Td/IPV should be given (2)

Oral polio vaccine is no longer available for routine use and will only be available for outbreak control (2).

Reference:

  1. Department of Health (August 10th 2004). New vaccinations for the childhood immunisation programme. PL/CMO/2004/3, PL/CNO/2004/2, PL/CPHO/2004/3.
  2. Department of Health (August 2004). Poliomyelitis - Green Book Update.
  3. https://www.nhs.uk/conditions/vaccinations/6-in-1-infant-vaccine/ (Accessed 26/4/19)

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.